La Merie SL provides consultancy services to all clients who wish a fully personal, individual, strictly confidential and exclusive collaboration on a specific subject. The extensive experience which La Merie has gained from exploring and analyzing the field of therapeutic proteins and biogeneric can be used for custom-tailored consultancy projects. Examples from the past are to identify candidates for Licensing-in of a biogeneric and to explore availability, to conduct primary intelligence (direct search) on selected biogenerics, to evaluate competitor projects in more detail, analysis of ongoing business deals (collaborations, licensing, M&A)..
Apart from biogenerics, La Merie is overseeing the whole R&D landscape which is materialized in its proprietary database of active R&D projects. The database is feeded by daily reviewing R&D news as well as , extracting information from our continues Competitor Analyses series and company pipelines and gathering information from scientific and corporate presentations, literature analysis and active desk top and primary search. La Merie has special focus on biologics including proteins and antibodies and on diabetes, cardiovascular diseases, inflammation and oncology.
Our clients are from Big Pharma to small biotech or medtech and come from Europe, the US or Japan. Recent consultancy projects include subjects such as new protein scaffolds and antibody technologies providing multi-specificity, benchmark analysis of companies with biologics pipeline, competitive and technical assessment of novel therapeutic protein …
If you are interested in our Consultancy Service, please feel free to contact us via phone, fax or e-mail and let us know your specific needs. We will be pleased to develop a project outline in response to your specific criteria and provide you with a time and cost proposal.
Passatge Jordi Ferran, 20
E-08028 Barcelona
T +34 93 342 91 97
F +34 93 342 91 98
Email info@lamerie.com
![Logo BiogenericsPipeline.com [Link to Homepage]](http://www.biogenericspipeline.com/wp-content/themes/biogenerics/images/biognericspipeline_logo.gif)

